Concepedia

Zhonghui Lu

ZL

Statistics

Publications

17

Citations

671

H-Index

14

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Bristol-Myers Squibb (India)

Biocon (India)

Zhonghui Lu is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacy, and pharmacology.

Publications per year

2002–2023

17

Publications

17

Discovery of γ-Lactam Hydroxamic Acids as Selective Inhibitors of Tumor Necrosis Factor α Converting Enzyme:  Design, Synthesis, and Structure−Activity Relationships

James J.‐W. Duan, Lihua Chen, Zelda R. Wasserman et al. · Journal of Medicinal Chemistry · 2002 · 119 citations · Full text

, , +17

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents

Zhonghui Lu, Gregory R. Ott, Rajan Anand et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 57 citations · Full text

, , +8

Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists

James J.‐W. Duan, Zhonghui Lu, Bin Jiang et al. · ACS Medicinal Chemistry Letters · 2019 · 54 citations · Full text

, , +17

Discovery of low nanomolar non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)

James J.‐W. Duan, Lihua Chen, Zhonghui Lu et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 53 citations · Full text

, , +11

Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches

Hai‐Yun Xiao, Ning Li, James J.‐W. Duan et al. · Journal of Medicinal Chemistry · 2020 · 49 citations · Full text

, , +14

1–5 of 17